Your browser doesn't support javascript.
loading
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang, Wei; Alvarado-Facundo, Esmeralda; Vassell, Russell; Collins, Limone; Colombo, Rhonda E; Ganesan, Anuradha; Geaney, Casey; Hrncir, David; Lalani, Tahaniyat; Markelz, Ana Elizabeth; Maves, Ryan C; McClenathan, Bruce; Mende, Katrin; Richard, Stephanie A; Schofield, Christina; Seshadri, Srihari; Spooner, Christina; Utz, Gregory C; Warkentien, Tyler E; Levine, Min; Coles, Christian L; Burgess, Timothy H; Eichelberger, Maryna; Weiss, Carol D.
Afiliação
  • Wang W; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Alvarado-Facundo E; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Vassell R; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Collins L; Defense Health Agency- Immunization Healthcare Division, Falls Church, Virginia, USA.
  • Colombo RE; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Ganesan A; Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Geaney C; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Hrncir D; Madigan Army Medical Center, Fort Lewis, Washington, USA.
  • Lalani T; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Markelz AE; Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Maves RC; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • McClenathan B; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
  • Mende K; Defense Health Agency- Immunization Healthcare Division Regional Office, Lackland AFB, Texas, USA.
  • Richard SA; Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Schofield C; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Seshadri S; Naval Medical Center, Portsmouth, Virginia.
  • Spooner C; Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
  • Utz GC; Division of Infectious Diseases, Naval Medical Center, San Diego, California, USA.
  • Warkentien TE; Defense Health Agency- Immunization Healthcare Division Regional Office, Ft. Bragg, North Carolina, USA.
  • Levine M; Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Coles CL; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
  • Burgess TH; Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
  • Eichelberger M; Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Weiss CD; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
Clin Infect Dis ; 73(11): e4312-e4320, 2021 12 06.
Article em En | MEDLINE | ID: mdl-32898271

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article